Five Valsartan Lawsuits Selected for Second Round of Bellwether Trials
Selections have been made in case the parties fail to negotiate Valsartan cancer settlements following a first round of bellwether trials expected to begin in late 2025.
Tag Archives: Drug Recall
-
-
Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for September 8, 2025
Parties will meet with the MDL judge today, to discuss issues scheduling the remaining bellwether trials selected by the Court.
-
Valsartan Liver Cancer Lawsuit Selected for First Jury Trial in MDL
First bellwether trial in the valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the most commonly reported injury caused by the recalled blood pressure drug.
-
Valsartan Cancer Lawsuits To Be Set for First Bellwether Trial, Instead of Third-Party Payor Claim
More than 1,270 Valsartan lawsuits are currently awaiting trial, most involving plaintiffs diagnosed with cancer following exposure to the recalled blood pressure drug, who are getting sicker and many are dying.
-
Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations
Judge hopes Valsartan recall lawsuit sanctions over discovery failures will serve as a deterrent to other foreign companies considering disregard for U.S. laws.
-
More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug
A joint report recommends that the first valsartan recall lawsuit be set to go before a jury in Fall 2024, after a prior trial scheduled to begin in March was postponed when the judge presiding over the litigation retired.
-
Valsartan Settlements Reached To Resolve Personal Injury, Class Action and Medical Monitoring Claims Against Hetero
Lawyers will seek preliminary approval for a settlement of valsartan lawsuits against the generic drug maker Hetero, but claims involving other manufacturers of contaminated valsartan pills remain unresolved
-
Valsartan Injury Lawyers To Meet With U.S. District Judge Recently Appointed To Preside Over Litigation
Parties indicate they have reached a proposed settlement agreement for certain Valsartan class action lawsuits and claims involving a similar drug, irbesartan.
-
Obsidio Conformable Embolic Recall Issued After Reports of Deaths, Serious Injuries
Boston Scientific reports that seven patients have been injured and two have died due to restricted blood flow caused by Obsidio Embolic side effects.
-
Valsartan Recall Lawsuit Cleared To Move Forward To Trial
The first valsartan recall lawsuit was scheduled to go to trial late last month, but the case was delayed and a new date has not yet been announced.
